Proscia

Invested in 2020

timeline

07/01/2014

Company founded

11/30/2020

Scale leads $23M Series B

Digitizing and reinventing the 150-year-old standard for pathology. Proscia’s Concentriq digital pathology platform and pipeline of AI-powered applications let laboratories leverage new kinds of data to accelerate discoveries and improve patient outcomes.

“Digitization has swept through almost every domain of healthcare, and we are now seeing its revolutionary impact on pathology.”


Alexander Niehenke, Partner at Scale Venture Partners